Business profile

JK Medical Consulting Oy

JK Medical Consulting Oy's registered office is Esbo. It is a limited company. The company was established on 1990-08-01. It operates in the industry of diagnostic imaging services and medical laboratory activities. In its latest retained statement for 2024-11-30, revenue was €64,940 and operating profit was €23,577.

Claim profileContact details
Business ID 0811136-2ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
0811136-2
Sector
Diagnostic imaging services and medical laboratory activities
Municipality
Esbo
Company form
Limited company
Registration date
1990-08-01
Business ID registration date
1990-09-19
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Riippakoivuntie 21 B, 02130, Esbo

About JK Medical Consulting Oy

Financial position and key figures for the company.

JK Medical Consulting Oy's location municipality is Esbo. It is a limited company. The company was established on 1990-08-01. It operates in the industry of diagnostic imaging services and medical laboratory activities. In its latest retained statement for 2024-11-30, revenue was €64,940 and operating profit was €23,577. The latest retained financial statement for 2024-11-30 shows revenue of €64,940 and profit for the financial year of €22,179. Based on the latest retained statement, revenue growth was -16.7%, operating margin was +36.3%, and equity ratio was +86.6%.

Financial highlights

Key figures from the latest financial period.

Open full statement
Latest financial period

2024-11-30

Imported periods2
PRH parsed2
Profile sourcePRH/XBRL financial statement
Derived indicators
Revenue growth-16.7%
Operating margin36.3%
Equity ratio86.6%
Revenue€64,940-€12,987 (-16.7%) vs previous periodPrevious: €77,928
Operating profit (loss)€23,577-€2,747 (-10.4%) vs previous periodPrevious: €26,324
Profit (loss) for the financial year€22,179-€3,832 (-14.7%) vs previous periodPrevious: €26,011
Assets€75,571+€27,166 (+56.1%) vs previous periodPrevious: €48,405
Balance-sheet contextLatest financial period
Cash and bank€51,735Previous: €25,112
Retained earnings€34,828Previous: €12,517
Equity€65,417Previous: €46,938
Liabilities€10,154Previous: €1,467
Current assets€55,078Previous: €26,032
Current liabilities€10,154Previous: €1,467
Revenue trend2 periods
€77,928
2023-11-30
€64,940
2024-11-30
Operating profit (loss) trend2 periods
€26,324
2023-11-30
€23,577
2024-11-30
Profit (loss) for the financial year trend2 periods
€26,011
2023-11-30
€22,179
2024-11-30
Assets trend2 periods
€48,405
2023-11-30
€75,571
2024-11-30

Financial ratios

Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.

Equity ratioGood
100/100 · Declining
86.6 %2023-11-30: 97.0 %
Current ratioGood
100/100 · Declining
5.10x2023-11-30: 17.11x
Operating profit marginGood
100/100 · Improving
36.3 %2023-11-30: 33.8 %
Ratio history
Ratio2023-11-302024-11-30
Equity ratio97.0 %86.6 %
Current ratio17.11x5.10x
Operating profit margin33.8 %36.3 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID0811136-2
EU IDFIFPRO.0811136-2
MunicipalityEsbo
Current registered entries
1990-08-01Registered in Patent and Registration Office (Trade Register)
1990-09-19Registered in Tax Administration (Tax Administration)
1995-03-01Registered in Tax Administration (Prepayment Register)

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
A2
Very goodJK Medical Consulting Oy
Grade unchangedA2 · new analysis 2026-10-18
Model score88/100
Assessment confidenceLow
Evidence qualityUsable financial evidenceFinancial data included
Financial trajectorySeveral key financial indicators have weakened across comparable fiscal periods.
2 comparable periods
RevenueDeteriorating
ProfitabilityImproving
SolvencyDeteriorating
LiquidityDeteriorating
Peer comparisonSame industryDescriptive comparison – does not change the model score.
111 peers
Solvency52%
Close to the peer-group midpoint
Profitability69%
Better than 69% of peers
Liquidity71%
Better than 71% of peers
Revenue growth18%
Below 82% of peers
Financial statement reporting patternRegularBased on observed PRH financial period end and registration dates. This descriptive evidence does not change the v0.14 score.
2 observed filings
Latest registration lag101 days after period end
Typical registration lag93 days after period end
Annual continuity2 consecutive periods
Supporting factors
  • Strong equity ratio
  • Strong operating profitability
  • Healthy short-term liquidity
Risk factors to note
  • Parsed financial metrics are older than the newest reported filing
  • Coordinated deterioration across 3 financial domains
Rating historyAutomatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
5 assessments
A2
2026-10-1888/100 · v0.15
A2 → A2
A2
2026-10-1788/100 · v0.15
A2 → A2
A2
2026-10-03 04:5388/100 · v0.14
A2 → A2 · +7 points
  • Evidence strengthened: a PRH/XBRL financial statement was added to the assessment (2024-11-30).
  • Assessment confidence: Medium → Low.
  • Evidence quality: Registry and statistical evidence → Usable financial evidence.
A2
2026-09-1581/100 · v0.14
Oldest retained automatic assessment in this comparison
Automatic model gradeA2
Automatic model snapshot2026-10-18
Automatic model versionopen-risk-grade-v0.15
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskvery low
92/100

Industry context is very low based on normalized open statistical inputs.

Age and continuityVakiintunut
90/100

The company has about 36 years of registry continuity.

Registry and status signalsVakaa
75/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
17 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A2.
Risk grade updatedRisk gradeEvidence verified
15 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A2.
Risk grade updatedRisk gradeEvidence verified
14 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1.

Registry timeline

Trade register notifications shown on a timeline.

16 register eventsLatest event: 2026-04-15

Financial statements availability

Available financial statement periods and PRH source filings.

2 financial statement periodsLatest financial period: 2024-11-30

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

JK Medical Consulting Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.